How does Innovent Biologics' mazdutide, a groundbreaking dual GLP-1/glucagon receptor drug just approved in China, compared to Wegovy and Zepbound? Read more here.

Zepbound is a prescription drug used to help with weight loss and sleep apnea in certain adults. The starting dosage for weight loss and sleep apnea is 2.5 mg injected once weekly for 4 weeks.

The effect of Novo Nordisk’s amycretin injections on body weight showed no signs of plateauing after 36 weeks, suggesting the ...

Since Zepbound was approved for weight loss in late 2023, it appeared to have an advantage over Wegovy. Patients taking the ...

BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of the GLP-1 field. | BrightGene Pharmaceutical has scored an early win in its push to topple the big beasts of ...

Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

A new study finds combining bimagrumab with Wegovy leads to significant fat loss without muscle loss. This breakthrough offers hope for safer obesity treatments but raises caution over possible side ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat.

Consider similar medications such as Wegovy. Wegovy is the exact same medication as Ozempic, but it's prescribed for weight loss, rather than diabetes. Your insurance may cover you for Wegovy instead ...